Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
2024 United States Cancer Supportive Care Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
Antibody Drug Conjugate Market by Target Disease Indication (Breast Cancer, B-cell Lymphoma, Lung Cancer, Multiple Myeloma, Acute Lymphoblastic Leukemia, Gastric Cancer, Renal Cancer, Cervical Cancer and Other Target Disease Indications), Therapeutic Area (Hematological Cancer and Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and Other Payloads), Target Antigens (HER-2 (ERBB2), CD79b, Trop-2, BCMA (TNFRSF17 / BCM), CD19, CD22, Tissue Factor, CD30, CEACAM5, Nectin 4 and Others) And Key Geographical Regions (North America (US, Canada), Europe (Germany, UK, France, Italy, Spain), and Asia-Pacific (China, Australia, Japan)): Industry Trends and Global Forecasts, Till 2035
... Solid Tumor), Linker (Valine-Citrulline, Succinimidyl-4-(N-Maleimidomethyl) Cyclohexane-1-Carboxylate, Tetrapeptide-based Linker, Maleimide, Maleimidocaproyl, Valine-Alanine, Hydrazone (4-(4-Acetylphenoxy) Butanoic Acid (AcBut) and Other Linkers), Payload (Monomethyl Auristatin E, DM1, Duocarmycin, SN-38 / Irinotecan, Monomethyl Auristatin F, SG3199, Ozogamicin, DM4 and ... Read More
-
2024 North America Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
-
2024 United Kingdom Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
-
2024 Europe Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Japan Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 India Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 Europe Lung Cancer Surgery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 Germany Lung Cancer Surgery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
Global Bladder Cancer Market 2024-2028
... on the bladder cancer market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the ... Read More
-
Global Hyperthermia Cancer Treatment Market 2024-2028
... period. The report on the hyperthermia cancer treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Artificial Intelligence in Drug Discovery Market by Process (Target, Lead), Use Case (Design & Optimisation: Vaccine, Antibody; Disease understanding, PK/PD), Therapy (Cancer, CNS, CVS), Tool (ML:DL (CNN, GAN)), End User & Region - Global Forecast to 2029
... to 2029 The global artificial intelligence (AI) in drug discovery market is projected to reach 6.89 billion by 2029 from 1.86 billion in 2024, at a CAGR of 29.9% from 2024 to 2029. Increasing cross-industry ... Read More
-
Cell and Gene Therapy Market Research Report Information by Therapy Type (Cell Therapy and Gene Therapy), Application (Cancer, Neurological Disorders, Cardiovascular Disorders, Rare Diseases, Ophthalmology, Blood Disorders and Others), and Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... and Rest of the World) Industry Forecast till 2032 In 2023, the e-Visa market was estimated to be worth USD 933.4 million. With a compound annual growth rate (CAGR) of 11.1% from 2024 to 2032, ... Read More
-
Non-Small Cell Lung Cancer (NSCLC) Therapeutics – A Global Market Overview
... spreading more slowly than small cell lung cancer. The primary subtypes of NSCLC include adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Adenocarcinoma, often located in the outer regions of the lung, accounts for about ... Read More
-
Lung Cancer Therapeutics – A Global Market Overview
... genetic damage to airway cells from smoking or exposure to harmful chemicals. This uncontrolled cell growth results in the formation of tumors, which can hinder lung function. Early-stage lung cancer often shows no symptoms and ... Read More
-
Cancer Immunotherapy - A Global Market Overview
... and radiation, which directly target cancer cells, immunotherapy enhances the immune response by utilizing tumor antigens that activate immune recognition. Monoclonal antibodies identify and tag cancer cells for elimination, while immune checkpoint inhibitors enhance the ... Read More
-
Head and Neck Cancer Therapeutics – A Global Market Overview
... the head and neck, including the lips, oral cavity (mouth), nasal cavity, pharynx (throat), larynx (voice box), salivary glands, and paranasal sinuses. These cancers are squamous cell carcinomas that usually begin from the flat cells ... Read More
-
Breast Cancer Therapeutics – A Global Market Overview
... invade nearby tissues or spread to other parts of the body. It is the most common cancer diagnosed in women, although it can also affect men, and the second most common cause of death from ... Read More
-
Cervical Cancer Treatment – A Global Market Overview
... dysplasia. If it is untreated, these abnormal cells can become cancerous and spread. There are three types of cervical cancers: squamous cell carcinomas, adenocarcinomas, and adenosquamous carcinomas. Cervical cancer treatment options are diverse, including chemotherapy, ... Read More
-
Oncology Precision Medicine Market
... growth of this market is the rising incidence of cancer. With an increasing number of cancer diagnoses, there is a heightened demand for personalized treatment options that target specific genetic mutations, ultimately enhancing treatment outcomes. ... Read More
-
Carcinoembryonic Antigen (CEA) Market
... largely driven by the rising incidence of cancers such as colorectal, lung, and breast cancers worldwide. According to the World Health Organization (WHO), the global cancer burden is expected to surge, with around 27 million ... Read More
-
Prostate Cancer Diagnostics
... by 2030, growing at a CAGR of 13.1% over the analysis period 2023-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$10.0 Billion by ... Read More
-
Chronic Myelogenous Leukemia Treatment
... reach US$10.1 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Disease Specific Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and ... Read More
-
United States Proton Therapy Market Report Forecast by Indication (Head & Neck Cancer, Sarcoma, Pediatric Cancer, Gastro-intestinal Cancer, Prostate Cancer, Lung Cancer, Set-up Type (Single Room, Multi – Room). States and Company Analysis 2025-2033
... States Proton Therapy Market Size United States Proton Therapy market had reached US$1,046.62 million in 2024 and is estimated to reach US$2,670.80 million during the forecast period from 2025 to 2033 at a compound annual ... Read More
-
Oncology Based In-Vivo CRO
... reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More
Research Assistance
